Imaging of atherosclerosis.
暂无分享,去创建一个
Z. Fayad | D. Owen | A. Lindsay | R. Choudhury | Z A Fayad | D R J Owen | A C Lindsay | R P Choudhury | Robin P. Choudhury | David R. Owen | Robin P. Choudhury
[1] Robert B. Innis,et al. Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands , 2011, The Journal of Nuclear Medicine.
[2] Roger N Gunn,et al. Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] A. Davies,et al. Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. , 2010, Journal of the American College of Cardiology.
[4] A. Davies,et al. Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced US. , 2010, Radiology.
[5] Ahmed Tawakol,et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. , 2010, JACC. Cardiovascular imaging.
[6] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[7] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[8] H. Sillesen,et al. Gene expression and 18FDG uptake in atherosclerotic carotid plaques , 2010, Nuclear medicine communications.
[9] Zahi A Fayad,et al. High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[10] R. Virmani,et al. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[11] Steven B. Feinstein,et al. Vasa Vasorum and Plaque Neovascularization on Contrast-Enhanced Carotid Ultrasound Imaging Correlates With Cardiovascular Disease and Past Cardiovascular Events , 2010, Stroke.
[12] Andrew E Arai,et al. Radiation Dose from Single-Heartbeat Coronary CT Angiography Performed with a 320 – Detector Row Volume Scanner 1 , 2010 .
[13] K. Chinnaiyan,et al. Annual progression of coronary calcification in trials of preventive therapies: a systematic review. , 2009, Archives of internal medicine.
[14] M. Robson,et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. , 2009, Journal of the American College of Cardiology.
[15] Matthias F Kriegel,et al. Assessment of coronary plaque progression in coronary computed tomography angiography using a semiquantitative score. , 2009, JACC. Cardiovascular imaging.
[16] M. Reiser,et al. 18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease , 2009, Journal of Nuclear Medicine.
[17] Z. Fayad,et al. HDL as a contrast agent for medical imaging , 2009, Clinical lipidology.
[18] Martin J Graves,et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. , 2009, Journal of the American College of Cardiology.
[19] O. Schober,et al. Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[20] Youbin Deng,et al. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. , 2009, Radiology.
[21] Jeroen J. Bax,et al. Lesions without calcium: lessons from CT angiography , 2009, Heart.
[22] J. Wykrzykowska,et al. Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation , 2009, Journal of Nuclear Medicine.
[23] D. Grobbee,et al. Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity: A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials , 2008, Circulation.
[24] M. Imaizumi,et al. Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis: an autoradiographic study with [(3)H]PK 11195. , 2008, Atherosclerosis.
[25] Hervé Boutin,et al. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[26] Frits Mastik,et al. Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque , 2008, Circulation.
[27] Z. Fayad,et al. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. , 2008, Small.
[28] Eun Jeong Lee,et al. Reversal of Vascular 18F-FDG Uptake with Plasma High-Density Lipoprotein Elevation by Atherogenic Risk Reduction , 2008, Journal of Nuclear Medicine.
[29] Roberto Chiesa,et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. , 2008, Journal of the American College of Cardiology.
[30] Bernd J Pichler,et al. Radionuclide imaging: a molecular key to the atherosclerotic plaque. , 2008, Journal of the American College of Cardiology.
[31] Sameer Bansilal,et al. Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations , 2008, Journal of Nuclear Medicine.
[32] M. Robson,et al. Early changes in arterial structure and function following statin initiation: Quantification by magnetic resonance imaging , 2008, Atherosclerosis.
[33] Moyses Szklo,et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.
[34] Zahi A. Fayad,et al. Imaging of atherosclerotic cardiovascular disease , 2008, Nature.
[35] Masahiro Fujita,et al. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors , 2008, NeuroImage.
[36] S. Neubauer,et al. Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[37] H. Schild,et al. Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans—first results , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[38] Steven B. Feinstein,et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? , 2007, Vascular medicine.
[39] G. Umpierrez,et al. The effects of extended‐release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome , 2007, International journal of clinical practice.
[40] Zahi A Fayad,et al. Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes , 2007, Journal of magnetic resonance imaging : JMRI.
[41] A. Einstein,et al. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. , 2007, JAMA.
[42] J. Lindner,et al. Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.
[43] F. Moll,et al. From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. , 2007, Trends in cardiovascular medicine.
[44] Zahi A Fayad,et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.
[45] Jean-Claude Tardif,et al. Effect of torcetrapib on the progression of coronary atherosclerosis. , 2007, The New England journal of medicine.
[46] Diederick E Grobbee,et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. , 2007, JAMA.
[47] W. B. Meijboom,et al. 64-Slice CT coronary angiography in patients with non-ST elevation acute coronary syndrome , 2007, Heart.
[48] Masatoshi Ishibashi,et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. , 2006, Journal of the American College of Cardiology.
[49] Ahmed Tawakol,et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.
[50] Chun Yuan,et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. , 2006, Radiology.
[51] Christof Karmonik,et al. Quantitation and Localization of Matrix Metalloproteinases and Their Inhibitors in Human Carotid Endarterectomy Tissues , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[52] Udo Hoffmann,et al. Arterial wall imaging: evaluation with 16-section multidetector CT in blood vessel phantoms and ex vivo coronary arteries. , 2006, Radiology.
[53] D. Nutt,et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.
[54] T. Yli-Kerttula,et al. Whole-body distribution of 11C-choline and uptake in knee synovitis , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[55] Roland Haubner,et al. αvβ3-integrin imaging: a new approach to characterise angiogenesis? , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[56] R. Virmani,et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. , 2006, Journal of the American College of Cardiology.
[57] Raimund Erbel,et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.
[58] B. Weber,et al. 18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[59] S. Kaul,et al. Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression , 2005, Circulation.
[60] Zahi A Fayad,et al. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.
[61] Ora Israel,et al. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[62] S. Radio,et al. Detection of retained microbubbles in carotid arteries with real-time low mechanical index imaging in the setting of endothelial dysfunction. , 2004, Journal of the American College of Cardiology.
[63] Antonio Colombo,et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. , 2004, European heart journal.
[64] Paul Schoenhagen,et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.
[65] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[66] P. Angelberger,et al. Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage , 2004, European Journal of Nuclear Medicine.
[67] Diederick E Grobbee,et al. Carotid Intima-Media Thickness Measurements in Intervention Studies: Design Options, Progression Rates, and Sample Size Considerations: A Point of View , 2003, Stroke.
[68] Paul Schoenhagen,et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.
[69] Chun Yuan,et al. Quantitative Magnetic Resonance Imaging Analysis of Neovasculature Volume in Carotid Atherosclerotic Plaque , 2003, Circulation.
[70] V. Fuster,et al. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.
[71] Chun Yuan,et al. Classification of Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance Imaging , 2002, Circulation.
[72] J. Pickard,et al. Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.
[73] Chun Yuan,et al. Identification of Fibrous Cap Rupture With Magnetic Resonance Imaging Is Highly Associated With Recent Transient Ischemic Attack or Stroke , 2002, Circulation.
[74] W. Kerwin,et al. Contrast‐enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization , 2002, Journal of magnetic resonance imaging : JMRI.
[75] C Yuan,et al. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. , 2001, Radiology.
[76] V. Fuster,et al. Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging , 2001, Circulation.
[77] H. Strauss,et al. Detection of Monocyte Chemoattractant Protein-1 Receptor Expression in Experimental Atherosclerotic Lesions: An Autoradiographic Study , 2001, Circulation.
[78] F Prati,et al. Correlation between high frequency intravascular ultrasound and histomorphology in human coronary arteries , 2001, Heart.
[79] C. Tracy,et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.
[80] René M. Botnar,et al. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden. , 2001, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[81] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[82] M. Matsuhisa,et al. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. , 2000, Diabetes care.
[83] V. Fuster,et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. , 2000, Circulation.
[84] S. Kaul,et al. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. , 2000, Circulation.
[85] S. Nakatani,et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. , 2000, Journal of the American College of Cardiology.
[86] S. Alper,et al. Hemodynamic shear stress and its role in atherosclerosis. , 1999, JAMA.
[87] M L Bots,et al. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). , 1999, Circulation.
[88] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[89] R H Selzer,et al. The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.
[90] W. Edwards,et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. , 1998, Journal of the American College of Cardiology.
[91] Arno W. Hoes,et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.
[92] E. Topol,et al. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. , 1995, Circulation.
[93] A. Zwinderman,et al. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. , 1995, The American journal of cardiology.
[94] M. Bond,et al. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. , 1995, Circulation.
[95] C. Rock,et al. Lysophosphatidylcholine and 1-O-Octadecyl-2-O-Methyl-rac- Glycero-3-Phosphocholine Inhibit the CDP-Choline Pathway of Phosphatidylcholine Synthesis at the CTP:Phosphocholine Cytidylyltransferase Step (*) , 1995, The Journal of Biological Chemistry.
[96] C. Furberg,et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) , 1995, The American journal of cardiology.
[97] Gerardo Heiss,et al. Carotid Artery Intimal‐Medial Thickness Distribution in General Populations As Evaluated by B‐Mode Ultrasound , 1993, Stroke.
[98] M. Di Loreto,et al. Immunodetection of human atherosclerotic plaque with 125I-labeled monoclonal antifibrin antibodies. , 1993, Atherosclerosis.
[99] S Glagov,et al. Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey. Localization, compensatory enlargement, and the sparing effect of lowered heart rate. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[100] Walter L. Henry,et al. Intravascular Ultrasound Imaging of Human Coronary Arteries In Vivo: Analysis of Tissue Characterizations With Comparison to In Vitro Histological Specimens , 1991, Circulation.
[101] A. Maseri,et al. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. , 1988, European heart journal.
[102] C. Zarins,et al. Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.
[103] W. Young,et al. The quantitation of atherosclerosis. II. Quantitative aspects of the relationship of blood pressure and atherosclerosis. , 1960, The American journal of cardiology.